Psoriasis Model
Creative Bioarray provides an extensive range of animal model services tailored specifically for psoriasis. Notably, we are good at swiftly delivering robust and consistently validated models at competitive rates, ensuring you receive high-quality results within your budget. Additionally, we pride ourselves on being able to customize new models to cater to your diverse and unique requirements, ensuring that your specific research needs are fully met. Whether you're looking for a standard model or a customized solution, our team of experts is here to support you every step of the way.
Psoriasis is a complex, autoimmune, and inflammatory skin condition identified by reddish, flaky plaques that progressively develop over time. Although it can affect anyone at any age, the most common age range is 50-69. Psoriasis is brought on by several circumstances, including trauma, heat, allergens, and stress. It is connected to various disorders and also impacts the skin, nails, and hair. Recent progress in biological therapies has revealed the fundamental roles of tumor necrosis factor-α, interleukin (IL)-23p19, and the IL-17A axis together with skin-resident immune cells and major signal transduction pathways in the pathogenesis of psoriasis.
Fig. 1 Proposed schema of the evolution of a psoriatic lesion from initiation to maintenance of disease
Our Animal Models of Psoriasis
For psoriasis research, novel drug discovery and development, Creative Bioarray has established the following psoriasis animal models for novel drug discovery and development.
Quotation and Ordering
At Creative Bioarray, we offer a diverse range of well-characterized psoriasis models, along with a variety of administration routes and clinically relevant endpoints. Our goal is to provide our clients with tailored solutions to meet their specific needs. If you are interested in our services, please feel free to contact us at any time or submit an inquiry to us directly.
Reference
- Nestle, F.O., et al. Psoriasis. N Engl J Med. 2009,30;361(5):496-509.
